title: Re: ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.
authors: EAU-Section of Urotechnology, Klinikdirektor Urologie, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, 74078 Heilbronn, Germany. jens.rassweiler@slk-kliniken.de
authors: Jens
authors: J
authors: Rassweiler
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000401:mortality* / Q000628:therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000401:mortality* / Q000628:therapy*; D008297:Male
chemical_list: D019496:Cancer Vaccines